Company intelligence / Profile preview

Zephyrus

Berkeley, California, United States

Ownership: Private
Development stage: Other

Overview

Zephyrus Biosciences developed innovative single-cell Western Blot technology, embodied in their Z1 System (Milo), enabling protein analysis at the individual cell level for research in fields like oncology and neurology. The technology was recognized as a top innovation of 2016 and the company was acquired by Bio-Techne in 2016.

Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Zephyrus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zephyrus.

Explore the full profile